For instance, this study identified recurrent PLAG1 and LYN rearrangements in four of five DLBCL/HGBCL cases suggests their potential as novel biomarkers, warranting further investigation into their oncogenic roles and therapeutic implications. The gene discussed is PLAG1; the disease is diffuse large B-cell lymphoma.